VITLVital Farms, Inc.
The Read
Vital Farms historically saw a median absolute move of about 17%.
The schedule
- Thu15Oct
Update on operational reset following the founder's departure and recent margin compression.
- Thu11Feb
Critical 'show me' quarter to prove margin sustainability amid macroeconomic shifts.
- Thu13May
FY2027 guidance release with heavily scrutinized year-over-year margin comparisons.
- Thu12Aug
Evaluation of spring seasonal demand and continued execution on the strategic cost plan.
Past
- Thu13Aug
Actual outcome: Bear · $10.90 at outcome
Vital Farms reported a Q2 net revenue decline of 10.1% to $166 million and a quarterly loss, driven by an industry oversupply of eggs, pricing gaps with branded competitors, and elevated costs tied to managing excess supply. These fundamental pressures on margins and revenue confirmed the bear case, driving the stock down 6.0%.
Q2 margins test if the guided contraction to 11.8% has stabilized.
- Tue16Jun
Actual outcome: Mixed · $10.41 at outcome
Vital Farms experienced a minor initial dip around the time of its securities class action hearing, but the stock subsequently surged past the $11.50 bull target. With no negative developments reported from the procedural test, shares were driven higher by broader positive momentum in the natural foods sector, as health-conscious consumers continue to fuel demand for ethically sourced products.
Vital Farms faces a critical procedural test in its ongoing securities class action regarding business disclosures.
- Tue3Mar
Actual outcome: Bear · $19.89 at outcome
Vital Farms missed Q4 EPS estimates and issued disappointing 2026 guidance, forecasting a significant contraction in adjusted EBITDA margins from 15.0% to 11.8%. The stock fell sharply below the bear floor as investors reacted to this margin compression, the retirement of the company's founder from the board, and a series of securities class action investigations regarding the company's business disclosures.
Vital Farms missed Q4 EPS estimates and issued disappointing 2026 guidance, forecasting a significant contraction in adjusted EBITDA margins from 15.0% to 11.8%. The stock fell sharply below the bear floor as investors reacted to this margin compression, the retirement of the company's founder from the board, and a series of securities class action investigations regarding the company's business disclosures.
